Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 20, 2020 07:00 ET | Source: ORGANICELL REGENERATIVE MEDICINE, INC

Organicell Partners with Regenerative Care Network to Study Potential Therapeutic Benefits of Zofin™ for Patients with Heart Failure

MIAMI, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine, Inc. (OTCBB: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,...
August 18, 2020 07:00 ET | Source: ORGANICELL REGENERATIVE MEDICINE, INC

Organicell Phase I/II Clinical Trial Update

MIAMI, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine, Inc. (OTCBB: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,...
August 13, 2020 07:00 ET | Source: ORGANICELL REGENERATIVE MEDICINE, INC

Organicell Completes Capital Raise from Retrograde Investments

MIAMI, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine, Inc. (OTCBB: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,...
August 06, 2020 07:00 ET | Source: ORGANICELL REGENERATIVE MEDICINE, INC

FDA Approves Two Emergency INDs for COVID-19 Outpatient Therapy

MIAMI, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine, Inc. (OTCBB: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,...
May 27, 2020 07:00 ET | Source: ORGANICELL REGENERATIVE MEDICINE, INC

Organicell Reports Positive Results from Compassionate Use of Organicell Flow in Severely Ill COVID-19 Patients

MIAMI, May 27, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine, Inc. (OTCBB:BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,...
May 19, 2020 07:00 ET | Source: ORGANICELL REGENERATIVE MEDICINE, INC

FDA Approves Two Emergency INDs to Administer Organicell Flow for COVID-19

MIAMI, May 19, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine, Inc. (OTCBB:BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,...
May 05, 2020 08:00 ET | Source: ORGANICELL REGENERATIVE MEDICINE, INC

Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19

MIAMI, May 05, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine, Inc. (OTCBB:BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,...
January 21, 2020 09:54 ET | Source: ORGANICELL REGENERATIVE MEDICINE, INC

Organicell Regenerative Medicine Inc. Provides Update On Operations and Financial Reporting Status

MIAMI, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine Inc. (OTCPK:BPSR) (the “Company”) is pleased to provide shareholders and the investment community with an update on...